Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis

Background: The detection of additional autoantibodies is of great concern in systemic sclerosis (SSc) when those included in the ACR/EULAR classification are negative. In this context, the interest of antifibrillarin (anti-U3RNP) autoantibodies (AFAs) in the routine evaluation of SSc remains unclea...

Descripción completa

Detalles Bibliográficos
Autores principales: Benyamine, Audrey, Bertin, Daniel, Resseguier, Noémie, Heim, Xavier, Bermudez, Julien, Launay, David, Dubucquoi, Sylvain, Hij, Adrian, Farge, Dominique, Lescoat, Alain, Bahon-Riedinger, Isabelle, Benmostefa, Nouria, Mouthon, Luc, Harlé, Jean-Robert, Kaplanski, Gilles, Rossi, Pascal, Bardin, Nathalie, Granel, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226926/
https://www.ncbi.nlm.nih.gov/pubmed/34207757
http://dx.doi.org/10.3390/diagnostics11061064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226926/
https://www.ncbi.nlm.nih.gov/pubmed/34207757
http://dx.doi.org/10.3390/diagnostics11061064

Ejemplares similares